![Adalimumab Humira Pen Injection at Rs 9837.5/box | Adalimumab Injections in Ahmedabad | ID: 25436614048 Adalimumab Humira Pen Injection at Rs 9837.5/box | Adalimumab Injections in Ahmedabad | ID: 25436614048](http://5.imimg.com/data5/SELLER/Default/2022/4/AE/RI/BM/150566867/adalimumab-humira-pen-injection.jpg)
Adalimumab Humira Pen Injection at Rs 9837.5/box | Adalimumab Injections in Ahmedabad | ID: 25436614048
![Humira <br> Crohn's Disease Starter Pack <br>Disease-Modifying Antirheumatic Agent Adalimumab, <br>Preservative Free 40 mg / 0.8 mL Subcutaneous <br>Injection Prefilled Auto-Injector Pen 6 Doses<br> Abbott 00074433906 Humira <br> Crohn's Disease Starter Pack <br>Disease-Modifying Antirheumatic Agent Adalimumab, <br>Preservative Free 40 mg / 0.8 mL Subcutaneous <br>Injection Prefilled Auto-Injector Pen 6 Doses<br> Abbott 00074433906](https://s.turbifycdn.com/aah/yhst-12533177228474/humira-crohn-s-disease-starter-pack-disease-modifying-antirheumatic-agent-adalimumab-preservative-free-40-mg-0-8-ml-subcutaneous-injection-prefilled-auto-injector-pen-6-doses-abbott-00074433906-30.gif)
Humira <br> Crohn's Disease Starter Pack <br>Disease-Modifying Antirheumatic Agent Adalimumab, <br>Preservative Free 40 mg / 0.8 mL Subcutaneous <br>Injection Prefilled Auto-Injector Pen 6 Doses<br> Abbott 00074433906
![REPEAT/Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator | Business Wire REPEAT/Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator | Business Wire](https://mms.businesswire.com/media/20230701798272/en/1832751/5/HADLIMA_adalimumab-bwwd_PushTouch_Autoinjector_Close-up.jpg)
REPEAT/Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator | Business Wire
![These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA ® (adalimumab) injection, for subcutaneous use Initial U.S. Approval: 2002 These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA ® (adalimumab) injection, for subcutaneous use Initial U.S. Approval: 2002](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=humira-44.jpg&id=743473)
These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA ® (adalimumab) injection, for subcutaneous use Initial U.S. Approval: 2002
![Adalimumab Pre Filled Syringe Injection 40 Mg / 0.8 Ml Dimension(L*W*H): 20 X 5 Feet Foot (Ft) at Best Price in Hyderabad | Healthway Speciality Pharma Adalimumab Pre Filled Syringe Injection 40 Mg / 0.8 Ml Dimension(L*W*H): 20 X 5 Feet Foot (Ft) at Best Price in Hyderabad | Healthway Speciality Pharma](https://tiimg.tistatic.com/fp/1/008/089/adalimumab-pre-filled-syringe-injection-40-mg-0-8-ml-717.jpg)
Adalimumab Pre Filled Syringe Injection 40 Mg / 0.8 Ml Dimension(L*W*H): 20 X 5 Feet Foot (Ft) at Best Price in Hyderabad | Healthway Speciality Pharma
![AbbVie and Eisai Announce the Launch of HUMIRA® Pen, an Auto-Injector Formulation for Fully Human Anti-TNF-α Monoclonal Antibody HUMIRA® | News Release:2018 | Eisai Co., Ltd. AbbVie and Eisai Announce the Launch of HUMIRA® Pen, an Auto-Injector Formulation for Fully Human Anti-TNF-α Monoclonal Antibody HUMIRA® | News Release:2018 | Eisai Co., Ltd.](https://www.eisai.com/news/2018/images/news201846-1.jpg)